Objective: The purpose of this study was to determine the role of Ureaplasma urealyticum-derived lipidassociated membrane proteins (LAMPs) in the host innate immune system, specifically their effect on Toll-like receptors (TLRs). Methods: LAMPs were derived from U. urealyticum strains, and human amniotic epithelial cells (HAECs) were isolated from healthy full-term placentas. Cytokine concentrations were determined by enzyme-linked immunosorbent assay (ELISA) and TLR2 mRNA by real-time PCR. Expression of TLR2 was confirmed by Western blotting and immunohistochemistry. Results: LAMPs induced HAECs to produce inflammatory cytokines interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α. Cytokine production was reduced after blocking TLR2 using TLR2 inhibitor (anti-hTLR2-IgA). Conclusions: LAMPs isolated from U. urealyticum induced TLR2-dependent up-regulation of inflammatory genes and cytokines in HAECs.
Introduction
Intra-amniotic infection is a primary cause of preterm birth. Studies have shown that Mycoplasma infection is an important risk factor for adverse pregnancy outcomes and low birth weight in infants (Viscardi, 2010; Capoccia et al., 2013) . Ureaplasma spp., belonging to the Mycoplasmataceae family, are the most common organisms isolated from the urogenital tracts of women who present with preterm labor (Viscardi, 2010) . Ureaplasma has 14 known serotypes and is divided into two biovars: Ureaplasma parvum and Ureaplasma urealyticum. Gerber et al. (2003) estimated that preterm birth occurs in 58.6% of U. urealyticum-positive women compared with only 4.4% in U. urealyticum-negative women.
Infection-induced preterm labor is an inflammatory process, where pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), sense microorganisms and their products. Chemokines (e.g. interleukin (IL)-1, IL-8, chemokine (C-C motif) ligand 2 (CCL-2)), cytokines (e.g. IL-1β, tumor necrosis factor (TNF)-α), prostaglandins, and proteases are produced, which lead to activation of the common pathway of parturition (Romero et al., 2001; Kannan et al., 2012) . Triantafilou et al. (2013) demonstrated that TLR2, TLR6, and TLR9 are involved in U. urealyticum-induced inflammation of human amniotic epithelial cells (HAECs) .
Mycoplasma lipid-associated membrane proteins (LAMPs) are cell-surface lipoproteins which induce potent inflammatory responses (He et al., 2009) . Several reports have confirmed that Mycoplasmaderived LAMPs can induce nuclear transcription factor κB (NF-κB) activation in human acute monocytic leukemia cell lines (Shimizu et al., 2008) and embryonic bovine lung (EBL) cells (He et al., 2009) .
Studies have revealed that it is possible to demonstrate the initial interaction between Mycoplasma membrane properties and host cells, such as leukocytes and epithelial cells (Shimizu et al., 2008; He et al., 2009; Choi et al., 2012 
Materials and methods

Preparation and culture of HAECs
Healthy full-term placentas were obtained with informed consent from women who had undergone a cesarean section at the Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China. The study was approved by the local research ethics committee.
HAECs were isolated from the placentas and cultured as follows (Liu et al., 2012) . Briefly, the membrane was placed in Dulbecco's modified Eagle medium (DMEM; HyClone, USA) and cut with a razor to yield 0.5-1.0 cm 2 segments. The segments were digested with 0.25% (2.5 g/L) trypsinethylenediaminetetraacetic acid (EDTA) at 37 °C for 45 min. The resulting cell suspensions were cultured in RPMI 1640 (HyClone, USA) containing 10% heat-inactivated fetal bovine serum (FBS; HyClone, USA), 2 mmol/L L-glutamine, 100 U/ml penicillin G, and 100 μg/ml streptomycin at 37 °C in a 5% CO 2 humid atmosphere.
Sample collection
The cultured HAEC cells were transferred to 12-well culture plates after the cell concentration was adjusted to 4×10 5 cells/well. The group of HAECs treated with LAMPs was regarded as the LAMP test group, and the HAECs treated with U. urealyticum were regarded as the U. urealyticum test group. Aqueous phase from the preparation of LAMPs (see below) was regarded as the negative control group.
Preparation and culture of U. urealyticum
U. urealyticum (ATCC 27618) was cultivated in modified Mycoplasma liquid broth (Oxoid, England) at 37 °C in a 5% CO 2 humid atmosphere. Cell density was measured and a concentration of 1×10 8 color forming units (CCU) per milliliter was used.
CCU was used for measuring U. urealyticum concentration. According to the metabolic activity of microbes in the culture medium, the relative content of microbes is counted. The method is described briefly: (1) 1.8 ml of the liquid Mycoplasma medium was added to each of 12 aseptic small tubes; (2) a 10-time gradient dilution was based on 1×10 0 -1×10 −11 ; (3) all tubes were cultured at 37 °C for 14 d. The highest dilution showing a color change in the culture medium, which corresponds to the maximum metabolic activity of Mycoplasma, was used as the CCU of the Mycoplasma to be tested.
Preparation of LAMPs
LAMPs were prepared as described previously (He et al., 2009) .
U. urealyticum was cultured in modified Mycoplasma solid medium (Oxoid, England) at 5% CO 2 , at 37 °C for 3-7 d until "fried egg" colonies were visible at low magnification. A single "fried egg" colony was then cultured in 500 ml of modified Mycoplasma liquid medium (Oxoid, England) at 5% CO 2 , at 37 °C for 3-7 d. When the medium color changed from red to yellow and was clear, it was regarded as indicating the logarithmic phase of U. urealyticum.
Cells of U. urealyticum in the logarithmic phase were centrifuged at 12 000g for 10 min and then the sediment was resuspended in 5 ml TBSE solution (50 mmol/L Tris (pH 8.0), 0.15 mmol/L NaCl, 1.0 mmol/L EDTA). A final concentration of 2% of Triton X-114 (TX-114) was added to lyse U. urealyticum at 4 °C for 1 h. Phase separation of the lysates of U. urealyticum occurred at 37 °C for 10 min. The upper aqueous phase separation, which was regarded as the negative control, was stored at −80 °C after 12 000g centrifugation for 20 min. The TBSE solution (4 °C) with an equal volume of TX-114 phase was added and mixed with the TX-114 phase at 4 °C for 10 min. The phase separation process was carried out three times.
The TX-114 phase was suspended with TBSE (4 °C) to the initial volume. After adding 2.5 times the volume of anhydrous alcohol, the whole suspension was left overnight at −20 °C to precipitate the membrane protein components. The precipitate was suspended in phosphate-buffered saline (PBS) after centrifugation. LAMPs were obtained after ultrasonic treatment. The protein concentration of the suspension was measured by the Bradford method (Coomassie blue protein assay).
HAECs stimulated with U. urealyticum or LAMPs
HAECs were seeded into 12-well plates at a concentration of 4×10 5 cells/well until the cells reached about 70%-80% confluence. HAECs were stimulated for 2, 6, or 24 h with the different concentrations (1.0-7.0 µg/ml) of LAMP or with U. urealyticum (1×10 8 CCU/ml). The supernatants were collected and frozen until the cytokine assays were performed. The expression of TLR2 mRNA was detected by real-time PCR after the cells were collected. Immunohistochemistry was used to detect the location of TLR2 in the cell.
TLR2 expression blocked by TLR2 inhibitor in HAECs
Anti-hTLR2-IgA (InvivoGen, USA), a TLR2 inhibitor (10 µg/ml), was added to the culture medium of HAECs for culture at 37 °C for 2 h, and then U. urealyticum (1×10 8 CCU/ml) or LAMPs (4 µg/ml) were added for 24 h. The culture solution was collected to detect cytokines. Immunohistochemistry was used to detect the location of TLR2 in the cell and the expression of TLR2 was detected by Western blotting.
Cytokine assays
Concentrations of cytokines in culture supernatants after stimulation were measured using enzymelinked immunosorbent assay (ELISA) kits (eBioscience, USA) according to the manufacturer's instructions. High-sensitivity ELISA kits were used to determine IL-6, IL-8, and TNF-α concentrations (the limits of detection were 0.10 , 0.05, and 0.13 pg/ml, respectively).
Real-time PCR assay
Total mRNA was extracted from infected and non-infected HAECs using TRIzol reagent (Invitrogen Carlsbad, CA, USA), according to the manufacturer's instructions. The RNA concentration was measured using a NanoDrop ND-2000 spectrophotometer (Life Technologies, USA). TLR2 mRNA in HAECs was determined by conducting quantitative SYBR ® Green-based real-time quantitative reverse transcription PCR (real-time qRT-PCR). All treatments were performed in triplicate. β-Actin was used as an internal control; two negative controls were also used in all RT-PCR experiments. The sequences of the primers used for real-time PCR were as follows: TLR2 sense, 5'-GGCCAGCAAATTACCTGTGTG-3'; TLR2 antisense, 5'-AGGCGGACATCCTGAACC-3'; TNF-α sense, 5'-TTCTCCTTCCTGATCGTGGC-3'; TNF-α antisense, 5'-TTCTCCTTCCTGATCGTGGC-3'; IL-8 sense, 5'-CTGGCCGTGGCTCTCTTG-3'; IL-8 antisense, 5'-CCTTGGCAAAACTGCACCTT-3'; IL-6 sense, 5'-CCACTCACCTCTTCAGAACG-3'; IL-6 antisense, 5'-CATCTTTGGAAGGTTCAGGTTG-3'; β-actin sense, 5'-GCTCTGGCTCCTAGCACCAT-3'; β-actin antisense, 5'-GCCACCGATCCACACAGA GT-3'.
Western blotting
Compared with control β-actin, the amount of TLR2 protein in HAECs was detected both by antibodies against TLR2 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and by Western blotting using enhanced chemiluminescence as specified by the manufacturer's instructions (GE Healthcare, Piscataway, NJ, USA).
Immunohistochemistry
HAECs infected with U. urealyticum or LAMPs were mounted on glass slides for 24 h. The cells were routinely processed and stained overnight with an appropriate concentration of a primary monoclonal antibody, followed by incubation with a horseradish peroxidase-conjugated secondary antibody.
Statistical analysis
Statistical comparisons were made using the t-test. The results are reported as mean±standard deviation (SD). P-values of <0.05 were considered statistically significant. All statistical analyses were performed with SPSS 20.0 software (IBM, USA).
Results
TLR2 mRNA expression in HAECs
TLR2 mRNA expression in HAECs varied depending on the concentration of LAMPs (1.0-7.0 µg/ml). Expression reached a maximum at a concentration of 4.0 µg/ml, and then remained largely unchanged at higher concentrations (Fig. 1) .
To determine whether TLR2 mRNA expression in HAECs stimulated with U. urealyticum (1×10 8 CCU/ml) or LAMPs (4.0 µg/ml) varied in relation to incubation time, HAECs were collected after incubation for 2, 6, or 24 h and tested by the following methods. Compared with the control group, expression of TLR2 mRNA was higher in HAECs infected with U. urealyticum or LAMPs for 6 or 24 h (P<0.01). After 2 h, TLR2 mRNA expression was higher in HAECs incubated with U. urealyticum than in the control or in HAECs incubated with LAMPs (P<0.05; Fig. 2 ).
TLR2 expression in HAECs induced by U. urealyticum or LAMPs
Immunohistochemical analysis showed that expression of TLR2 occurred after stimulation with U. urealyticum or LAMPs, and was repressed following treatment with TLR2 inhibitor, suggesting that expression of TLR2 was associated with stimulation by U. urealyticum or LAMPs (Fig. 3) .
Compared to the control, TLR2 expression was significantly higher in HAECs after infection with U. urealyticum or treatment with LAMPs for 24 h (P<0.01). TLR2 expression in HAECs was inhibited by TLR2 inhibitor in the U. urealyticum group (P<0.05) and the LAMP group (P<0.01) (Fig. 4) .
Cytokine production induced by U. urealyticum and LAMPs in HAECs
As HAECs are commonly used as models for the human amnion, we initially tested the ability of U. urealyticum and LAMPs to stimulate the production of various cytokines in HAECs. HAECs were incubated with U. urealyticum (1×10 8 CCU/ml) or LAMPs (4.0 µg/ml) for up to 24 h. Compared with the control group, HAECs produced significantly more cytokines (IL-6, IL-8, TNF-α) after stimulation with U. urealyticum or LAMPs for 24 h (P<0.01; Fig. 5 ).
U. urealyticum-or LAMP-mediated production of cytokines inhibited by TLR2 inhibitor
HAECs were treated with TLR2 inhibitor for 2 h before incubation with U. urealyticum or LAMPs, and cytokines in the supernatants were measured after incubation for 24 h (Fig. 6) . The control group of HAECs was treated with PBS or TLR2 inhibitor. The results showed that after treatment with TLR2 inhibitor, cytokine production by HAECs infected with U. urealyticum or treated with LAMPs was significantly lower than that by HAECs treated with PBS (P<0.01).
Discussion
To our knowledge, this is the first report of U. urealyticum-derived LAMPs stimulating HAECs to express TLR2. A growing body of evidence suggests that the presence of U. urealyticum in the amniotic cavity correlates with an adverse effect on pregnancy outcomes and complications of preterm birth. Previous studies (Abele-Horn et al., 2000; Kwak et al., 2014) have demonstrated that the incidence of preterm delivery, low Apgar scores, neonatal intensive care unit (NICU) admission, and histologic chorioamnionitis are directly correlated with the level of U. urealyticum colonization. High levels of cytokines in the amniotic fluid may serve as an indicator of bacterial infection and can predict subsequent pregnancy loss (Daskalakis et al., 2009) . A shift in signaling from anti-inflammatory to pro-inflammatory pathways plays an important role in adverse outcomes of preterm birth (Wenstrom et al., 1996) .
In this study, U. urealyticum-derived LAMPs and U. urealyticum were capable of inducing secretion of pro-inflammatory cytokines IL-6, IL-8, and TNF-α after the host cells were treated for 24 h. These results are similar to those of Wang et al. (2016) who found that Mycoplasma bovis-derived LAMPs can activate IL-1β production via TLR2. He et al. (2009) reported that Mycoplasma genitalium-derived LAMPs can activate the immune system of the cell. This study built on previous research which determined that U. urealyticum or Ureaplasma spp. trigger the secretion of pro-inflammatory cytokines (Triantafilou et al., 2013) . Since LAMPs are the major surface proteins of U. urealyticum, it seemed likely that they may play a role in the induction of cytokine expression.
We confirmed that U. urealyticum-derived LAMPs can induce cytokine expression in HAECs and that TLR2 was involved in triggering proinflammatory responses in response to them. There is (Triantafilou et al., 2013) . Our experiments confirmed that TLR2 is involved in activation of the inflammatory cascade. While LAMPs did not induce cytokine expression as strongly as whole cell U. urealyticum, which stimulated HAECs to express TLR2 within 2 h, they activated TLR2 after 6 h ( Fig. 2) . TLR2 has been identified as a receptor that is important to the innate immune response and transmits signaling pathways via IL-1 receptor (IL-1R)-associated signal molecules, such as myeloid differentiation factor 88 (MyD88), mitogen-activated protein kinases (Sweet and Schorey, 2006; Lyu et al., 2017) . Further research is needed to confirm which intracellular pathway is involved in this interaction. Inhibition of the interaction between TLRs and lipoproteins may result in a reduction of the inflammatory response induced by LAMPs. After HAECs were treated with TLR2 inhibitor, cytokine production was significantly reduced in HAECs treated with either LAMPs or U. urealyticum (Fig. 2) . Pre-treatment with inhibitors offers promise as a protective means to lower the activity of cytokines. Glushkova et al. (2013) found that inhibitors of TLR4 signaling reduced the toxic effect of lipopolysaccharide. The results of our study might help in the search for new TLR-based therapeutic targets for LAMPs and U. urealyticuminduced chorioamnionitis.
Our data showed that TLR2 mRNA expression continued to rise to some extent as the concentration of LAMPs increased. The fact that LAMPs and U. urealyticum engage TLR2 might reveal the reasons why U. urealyticum can cause the development of chronic, low-level inflammation of amniotic epithelial cells leading to irreversible injury of fetal membranes. Activation via TLR2 results in a soft inflammatory response allowing the LAMPs to establish a chronic foothold in amniotic epithelial cells.
Taken together, our data indicate that U. urealyticum-derived LAMPs have potent inflammatory properties and can mediate changes in gene Our studies suggest that using the inhibitor anti-hTLR2-IgA to inhibit the signaling pathway can result in a reduction in the downstream expression of several pro-inflammatory cytokines. Our data also sustain the notion that U. urealyticum may have additional mechanisms for inducing inflammatory responses in HAECs beyond those mediated by LAMPs. There were several limitations inherent in this study. First, we detected only three kinds of cytokines; more chemokines should be investigated in further studies. Second, although we confirmed that cytokine expression was reduced after blocking TLR2, other TLRs may play a similar role and should be investigated.
Conclusions
This is the first investigation into the effects of U. urealyticum-derived LAMPs on the expression of cytokines IL-6, IL-8, and TNF-α in HAECs via TLR2.
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